Literature DB >> 19384585

Protective effect of memantine against Doxorubicin toxicity in primary neuronal cell cultures: influence a development stage.

D Jantas1, W Lason.   

Abstract

One of the serious unwanted effects of the anthracycline anticancer drug doxorubicin (Dox, adriamycin) is its neurotoxicity, which can be evoked by the activation of extracellular (FAS/CD95/Apo-1) pathway of apoptosis in cells. Since memantine, a clinically used N-methyl-D: -aspartic acid (NMDA) receptor antagonist, shows antiapoptotic action in several models of neuronal cell damage, in this study we evaluated the effect of memantine on the cell death induced by Dox in primary neuronal cell cultures. First, we investigated the effect of different concentrations of Dox (0.1-5 microM) on mouse neocortical, hippocampal, striatal, and cerebellar neurons on 7- and 12-day in vitro (DIV). The 7 DIV neuronal cell cultures were more prone to Dox-induced cell death than 12 DIV cultures. The cerebellar neurons were the most resistant to Dox-induced apoptosis in comparison to neuronal cell cultures derived from the forebrain. Memantine (0.1-2 microM) attenuated the Dox-evoked lactate dehydrogenase release in 7 DIV neuronal cell cultures with no significant effect on 12 DIV cultures. The ameliorating effect of memantine on Dox-mediated cell death was also confirmed by an increase in cell viability measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction assay. There was no effect of memantine on Dox-induced caspase-8 and -3 activity and Dox-evoked decrease in mitochondrial potential, although attenuation in the number of cells with apoptotic DNA fragmentation was observed. We also showed that the antiapoptotic effect of memantine in our model was NMDA receptor-independent, since two other antagonists of this receptor, MK-801 and AP-5, did not attenuate Dox-induced cell death. Furthermore, memantine did not influence the Dox-evoked increase in cytoplasmic Ca2+ level. The obtained data suggest developmental regulation of both, the Dox-mediated neurotoxicity and efficacy of memantine in alleviating the Dox-induced cell damage in neuronal cell cultures. Moreover, this neuroprotective effect of memantine seems not to be dependent on caspase-3 activity and on the antagonistic action on NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384585     DOI: 10.1007/s12640-009-9002-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  65 in total

Review 1.  Apoptotic signaling cascades.

Authors:  Paula C Ashe; Mark D Berry
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-04       Impact factor: 5.067

2.  Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus.

Authors:  G J Brewer
Journal:  J Neurosci Res       Date:  1995-12       Impact factor: 4.164

3.  FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35.

Authors:  Christoph P Beier; Jörg Wischhusen; Marc Gleichmann; Ellen Gerhardt; Ana Pekanovic; Andreas Krueger; Verdon Taylor; Ueli Suter; Peter H Krammer; Matthias Endres; Michael Weller; Jörg B Schulz
Journal:  J Neurosci       Date:  2005-07-20       Impact factor: 6.167

4.  Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture.

Authors:  L J McIntosh; R M Sapolsky
Journal:  Exp Neurol       Date:  1996-10       Impact factor: 5.330

5.  Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention.

Authors:  W E Müller; G Pergande; H Ushijima; C Schleger; M Kelve; S Perovic
Journal:  Prog Mol Subcell Biol       Date:  1996

6.  Anticancer agents are potent neurotoxins in vitro and in vivo.

Authors:  Wojciech Rzeski; Susanne Pruskil; Alexander Macke; Ursula Felderhoff-Mueser; Anne Katrin Reiher; Friederike Hoerster; Corina Jansma; Bozena Jarosz; Vanya Stefovska; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

7.  Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death.

Authors:  Joseph H Su; Aileen J Anderson; David H Cribbs; Christina Tu; Liqi Tong; Patrick Kesslack; Carl W Cotman
Journal:  Neurobiol Dis       Date:  2003-04       Impact factor: 5.996

8.  Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia.

Authors:  M Wetzel; L Li; K M Harms; T Roitbak; P B Ventura; G A Rosenberg; R Khokha; L A Cunningham
Journal:  Cell Death Differ       Date:  2007-10-26       Impact factor: 15.828

9.  FasL, Fas, and death-inducing signaling complex (DISC) proteins are recruited to membrane rafts after spinal cord injury.

Authors:  Angela R Davis; George Lotocki; Alex E Marcillo; W Dalton Dietrich; Robert W Keane
Journal:  J Neurotrauma       Date:  2007-05       Impact factor: 5.269

10.  Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis.

Authors:  M Wetzel; G A Rosenberg; L A Cunningham
Journal:  Eur J Neurosci       Date:  2003-09       Impact factor: 3.386

View more
  10 in total

1.  The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain.

Authors:  Simon M Manning; Griffin Boll; Erin Fitzgerald; Debra B Selip; Joseph J Volpe; Frances E Jensen
Journal:  Int J Dev Neurosci       Date:  2011-05-20       Impact factor: 2.457

2.  Extremely low frequency magnetic field induces human neuronal differentiation through NMDA receptor activation.

Authors:  Alp Özgün; Ana Marote; Leo A Behie; António Salgado; Bora Garipcan
Journal:  J Neural Transm (Vienna)       Date:  2019-07-17       Impact factor: 3.575

3.  Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture.

Authors:  Boglarka Racz; Dora Reglodi; Gabriella Horvath; Andras Szigeti; Borbala Balatonyi; Erzsebet Roth; Gyorgy Weber; Nasri Alotti; Gabor Toth; Balazs Gasz
Journal:  J Mol Neurosci       Date:  2010-04-20       Impact factor: 3.444

4.  Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathways.

Authors:  Kaliris Y Salas-Ramirez; Ciara Bagnall; Leslie Frias; Syed A Abdali; Tim A Ahles; Karen Hubbard
Journal:  Behav Brain Res       Date:  2015-06-19       Impact factor: 3.332

Review 5.  Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors.

Authors:  Md Jakaria; Shin-Young Park; Md Ezazul Haque; Govindarajan Karthivashan; In-Su Kim; Palanivel Ganesan; Dong-Kug Choi
Journal:  Front Mol Neurosci       Date:  2018-08-29       Impact factor: 5.639

6.  Mitoxantrone is More Toxic than Doxorubicin in SH-SY5Y Human Cells: A 'Chemobrain' In Vitro Study.

Authors:  Daniela Almeida; Rita Pinho; Verónica Correia; Jorge Soares; Maria de Lourdes Bastos; Félix Carvalho; João Paulo Capela; Vera Marisa Costa
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-05

7.  Losing Control: Excessive Alcohol Seeking after Selective Inactivation of Cue-Responsive Neurons in the Infralimbic Cortex.

Authors:  Simone Pfarr; Marcus W Meinhardt; Manuela L Klee; Anita C Hansson; Valentina Vengeliene; Kai Schönig; Dusan Bartsch; Bruce T Hope; Rainer Spanagel; Wolfgang H Sommer
Journal:  J Neurosci       Date:  2015-07-29       Impact factor: 6.167

8.  The predominant protective effect of tianeptine over other antidepressants in models of neuronal apoptosis: the effect blocked by inhibitors of MAPK/ERK1/2 and PI3-K/Akt pathways.

Authors:  D Jantas; S Krawczyk; W Lason
Journal:  Neurotox Res       Date:  2013-10-09       Impact factor: 3.911

9.  A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.

Authors:  Faezeh Ajorloo; Mohammad Vaezi; Alireza Saadat; Seyed Reza Safaee; Behrouz Gharib; Mostafa Ghanei; Seyed Davar Siadat; Farzam Vaziri; Abolfazl Fateh; Mehrdad Pazhouhandeh; Behrouz Vaziri; Reza Moazemi; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani
Journal:  PLoS One       Date:  2017-09-11       Impact factor: 3.240

10.  A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway.

Authors:  Nasia Antoniou; Dimitrios Vlachakis; Anna Memou; Emmanouela Leandrou; Polytimi-Eleni Valkimadi; Katerina Melachroinou; Diane B Re; Serge Przedborski; William T Dauer; Leonidas Stefanis; Hardy J Rideout
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.